OBJECTIVE: To analyse the cost-effectiveness of a screening programme and follow-up interventions for @entity1 with dysglycemia who are identified during a dental visit. METHODS: This study is a secondary analysis utilizing data from two relevant publications. Those studies identified @entity1 with dysglycemia who were seen in a dental school clinic for routine dental care and determined compliance with a recommendation to seek medical care. The response site was 59.4%. The Archimedes disease simulation model was utilized to simulate the effect of a weight loss programme for identified subjects on several outcomes. RESULTS: Two scenarios for weight loss programmes were considered: a 10% permanent @entity353 and a 10% loss that decays over time. Both @entity6 and @entity5710 were analysed. The decay path costs  21 243 per quality adjusted life year (QALY) with 3 years required to achieve the @entity353 . This cost decreases to  6655 if only 1 year is needed to achieve the weight goal. Without decay, the cost per QALY is  15 873 with 20 years of intervention, vs  647 per QALY with 10 years of intervention. For individuals with @entity6 , the cost per QALY is  48 604 to  56 207 depending on adherence. With the addition of oral medication (a @entity5736 ), the cost is three times higher. CONCLUSIONS: Under the conditions described here, identification of @entity1 with dysglycemia in the dental office for initiating @entity5710 care is a cost-effective means of identifying and treating affected individuals.

Cost-effectiveness of XXXX screening initiated through a dental visit.

@entity1 :: ('9606', 'Species') :: ['persons'] @entity353 :: ('MESH:D015431', 'Disease') :: ['weight reduction', 'loss in body weight'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes', 'type 2 diabetes mellitus'] @entity5710 :: ('MESH:D011236', 'Disease') :: ['prediabetes', 'prediabetic'] @entity5736 :: ('D013453', 'Chemical') :: ['sulfonylurea']
@entity6 :: (MESH:D003920,Disease) :: ['diabetes']
